Initiative / Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection

Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection

Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection

Studies 2
Assess the effects of different antibiotic treatment strategies on survival of elderly nursing home residents with lower respiratory tract infections in the United States and the Netherlands, where treatment approaches are quite different.
Investigators Contacts
  • Dr. Jenny T. Van der Steen
    Leiden University Medical Center
  • Dr. David R. Mehr
    University of Missouri-Columbia
  • Dr. Robin L Kruse
    University of Missouri-Columbia

General Information

Types of cohorts
  • Patient/disease cohort
Countries
  • Netherlands
  • United States of America
Setting
International
Funding
Grants from the National Institute on Aging(US), Agency for Healthcare Research and Quality(US), Robert Wood Johnson Foundation(US), Dutch Ministry of Health, Welfare and Sport(Netherlands) and the Society ‘Het Zonnehuis’(Netherlands)
Criteria of cohort's to be included
Cohorts that the researchers recruited in previous research projects.
Health topic
  • Ageing
  • Respiratory diseases
Socio-environmental context
  • Other : Nursing homes

Participants

Number of participants

Total
1,221
With harmonized data
1,221

Age range of the samples

Minimum age
70

Methodology for harmonization and integration

Strategy of harmonization
Ex-post
Data processing methods
  • NA
  • Type of infrastructure
    Data are in different locations
    Integrative data analysis
    • Pooled analyses
    Software
  • SAS
  • Supplementary information
    Kruse RL et al. Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection: a cross-national analysis. Ann Fam Med. 2005 Sep-Oct;3(5):422-9

    Number of cohorts

    Total
    2
    With harmonized data
    2
    Will more cohorts be harmonized?
    Number of harmonized variables (max.)
    40

    Access

    Availability of metadata
    Availability of individual data

    Individual Studies

    Acronym Name Study design Participants Countries
    Mehr_Jama_2001 Missouri Lower Respiratory Tract Infection Study Patients' cohort 1,044
    van der Steen_Med Decis Making_2005 Dutch Pneumonia Study Patients' cohort 415